Research line

Diagnosis, monitoring, quantification and risk stratification of cardiac dysfunctions from automatic analysis of multilead ECG, including:

  1. Automatic ECG wave delineation and characterization
  2. Detection and monitoring of cardiac ischemia
  3. Identification of repolarization alternans, as a marker of arrhythmic risk
  4. Study of the relationship between heart rate and the repolarization morphology and duration (T wave, QT interval) in stationary and non-stationary scenarios, as a marker of arrhythmic risk
heart

Technologies and targeting sectors

  • Technology 1

Signal processing software for automatic ECG detection and delineation.

Targeting sector: Biomedical Engineering companies

  • Technology 2

Arrhythmia risk marker extraction form ECG to quantify arrhythmia risk.

Targeting sector: Biomedical Engineering companies

Patents and technology transfer

  • Case 1

Technology transfer agreement with the company Cardiac Markers to transfer the repolarization alternans detection technology.

  • Case 2

Technology transfer agreement with the company CardioLund to develop a web-based site for remote ECG signal analysis.

Singular equipment

Biomedical acquisition lab, including a tilt table set

Finometer for blood pressure measurement

BIOPAC system for data acquisition

Finished Projects